167 related articles for article (PubMed ID: 23467843)
1. Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer Cells.
Fu XS; Li PP
Chin J Cancer Res; 2011 Sep; 23(3):208-13. PubMed ID: 23467843
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.
Zhou N; Han SY; Zhou F; Li PP
J Ethnopharmacol; 2014 Jul; 154(3):687-95. PubMed ID: 24809288
[TBL] [Abstract][Full Text] [Related]
3. Shu-Gan-Liang-Xue Decoction, a Chinese herbal formula, down-regulates the expression of steroid sulfatase genes in human breast carcinoma MCF-7 cells.
Zhang Y; Li PP
J Ethnopharmacol; 2010 Feb; 127(3):620-4. PubMed ID: 20015473
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of estrogenic potential of Shu-Gan-Liang-Xue Decoction by dual-luciferase reporter based bioluminescent measurements in vitro.
Zhang Y; Li PP
J Ethnopharmacol; 2009 Nov; 126(2):345-9. PubMed ID: 19703548
[TBL] [Abstract][Full Text] [Related]
5. Shugan Liangxue Decoction () Down-Regulates Estrogen Receptor α Expression in Breast Cancer Cells.
Zhou N; Han SY; Chen YZ; Zhou F; Zheng WX; Li PP
Chin J Integr Med; 2018 Jul; 24(7):518-524. PubMed ID: 26740221
[TBL] [Abstract][Full Text] [Related]
6. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells.
van de Ven J; Donker GH; Sprong M; Blankenstein MA; Thijssen JH
J Steroid Biochem Mol Biol; 2002 Jul; 81(3):237-47. PubMed ID: 12163135
[TBL] [Abstract][Full Text] [Related]
7. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
8. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
[TBL] [Abstract][Full Text] [Related]
9. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
Rasmussen LM; Zaveri NT; Stenvang J; Peters RH; Lykkesfeldt AE
Breast Cancer Res Treat; 2007 Dec; 106(2):191-203. PubMed ID: 17268816
[TBL] [Abstract][Full Text] [Related]
10. In vitro interactions between mammary fibroblasts (Hs 578Bst) and cancer epithelial cells (MCF-7) modulate aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases.
Wang X; Sang X; Diorio C; Lin SX; Doillon CJ
Mol Cell Endocrinol; 2015 Sep; 412():339-48. PubMed ID: 26044867
[TBL] [Abstract][Full Text] [Related]
11. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo.
James MR; Skaar TC; Lee RY; MacPherson A; Zwiebel JA; Ahluwalia BS; Ampy F; Clarke R
Endocrinology; 2001 Apr; 142(4):1497-505. PubMed ID: 11250930
[TBL] [Abstract][Full Text] [Related]
13. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
Sang X; Han H; Li T; Lin SX
J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
[TBL] [Abstract][Full Text] [Related]
14. Long-term chinese herbs decoction administration for management of hot flashes associated with endocrine therapy in breast cancer patients.
Xue D; Sun H; Li PP
Chin J Cancer Res; 2011 Mar; 23(1):74-8. PubMed ID: 23467638
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells.
Łuczak MW; Jagodziński PP
Biomed Pharmacother; 2009 May; 63(4):262-6. PubMed ID: 18602794
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Stute P; Götte M; Kiesel L
Breast Cancer Res Treat; 2008 Apr; 108(3):363-74. PubMed ID: 17546497
[TBL] [Abstract][Full Text] [Related]
17. Steroid sulfatase activity and expression in mammary myoepithelial cells.
Tobacman JK; Hinkhouse M; Khalkhali-Ellis Z
J Steroid Biochem Mol Biol; 2002 May; 81(1):65-8. PubMed ID: 12127043
[TBL] [Abstract][Full Text] [Related]
18. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
19. Sources of estrogen and their importance.
Simpson ER
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
